Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Expanding our virtual healthcare platform to include weight management is part of our ongoing commitment to listening to patients and the services they want from their local pharmacy, said Rick Gates, chief pharmacy officer at Walgreens, in a statement
As with any emerging treatment, we know our patients have questions
179 Orforglipron is a non-peptide oral GLP-1 RA which has completed phase 2 trials and has shown weight reduction ranging from 8.6% to 12.6% along with improved hemoglobin A1C
J Clin Endocrinol Metab (2017) 102(11):413647
Most protocols call for 1 to 2 sprays per nostril once daily
Diabetes Prevention: Near-Complete Reversal in Prediabetes The SURMOUNT-1 extension trial followed patients with prediabetes and obesity on tirzepatide for 176 weeks
US$ 26.38
US$ 20.24
US$ 22.72
US$ 22.93
US$ 29.36
